BrianBBergerMDboard certified
Ophthalmology • Austin, TXRetinal Disease, Uveitis
president, Retina Research Center
Dr. Berger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3705 Medical Parkway
Suite 410
Austin, TX 78705Phone+1 512-454-5851Fax+1 512-454-5853- Is this information wrong?
Education & Training
Medical College of Wisconsin Affiliated HospitalsResidency, Ophthalmology, 1979 - 1980
University of Illinois College of Medicine at ChicagoResidency, Ophthalmology, 1976 - 1979
Valleywise HealthInternship, Transitional Year, 1975 - 1976
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1975
Certifications & Licensure
TX State Medical License 1981 - 2024
IL State Medical License 1976 - 2014
WI State Medical License 1979 - 1981- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Top Doctors:SE Texas Castle Connolly, 2013
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) Start of enrollment: 2010 Jun 01
- Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control Start of enrollment: 2011 Oct 01
- A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study) Start of enrollment: 2012 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsArchway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results.Carl Regillo, Brian Berger, Logan Brooks, W Lloyd Clark, Robert Mittra, Charles C Wykoff, Natalia F Callaway, Stephanie DeGraaf, Han Ting Ding, Anne E Fung, Shamika Gu...> ;Ophthalmology. 2023 Jul 1
- 2 citationsImplantation Site of a Port Delivery System With Ranibizumab: Anterior Segment Optical Coherence Tomography Evaluation.Cory A Christensen, Brian Berger, Shamika Gune, Jared S Nielsen, Ericksen, C. J., Connor J Ericksen> ;Journal of Vitreoretinal Diseases. 2022 Aug 4
- 3 citationsRanibizumab Injection (Susvimo) Implant Septum Dislodgement in a Patient With Neovascular Age-Related Macular Degeneration.Kaitlyn Timmons, Luke C Heckmann, Yong Ren, Ivana Gunderson, Fuad Makkouk, Brian B Berger> ;JAMA Ophthalmology. 2022 Aug 1
- Join now to see all
Journal Articles
- A CCR2/5 Inhibitor, PF-04634817, Is Inferior to Monthly Ranibizumab in the Treatment of Diabetic Macular EdemaBrian Berger, Douglas Girgenti, Ronald A Schachar, Marla B Sultan, Investigative Ophthalmology and Visual Science
Press Mentions
Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
Professional Memberships
- Fellow
Other Languages
- Spanish
Hospital Affiliations
University Medical Center at BrackenridgeAustin, Texas
St. David's Medical CenterAustin, Texas
Ascension Seton Medical Center AustinAustin, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
